All Stories

Emergent lands $62.4M upgrade to botulism antitoxin supply pact with US

A little less than a year after topping up its medical countermeasure contracts with Emergent BioSolutions, the federal government is back for more.

Jun 26, 2025 - 16:25
 0
Emergent lands $62.4M upgrade to botulism antitoxin supply pact with US
A little less than a year after topping up its medical countermeasure contracts with Emergent BioSolutions, the federal government is back for more.
Read More

Tags:

Previous Article

Vor Bio's surprise $4B revival deal for RemeGen's autoimmune drug triggers diver...

Next Article

Abbott in partnership focused on producing pharmaceuticals in Abu Dhabi

Related Posts

Regulatory tracker: England's NICE signs off on 'managed access period' for BioMarin rare disease drug

Regulatory tracker: England's NICE signs off on 'manage...

May 15, 2025  0

SK defeats Pfizer in Korean patent feud, opening new lines of business for pneumococcal vaccine

SK defeats Pfizer in Korean patent feud, opening new li...

May 21, 2025  0

Biosynthesis specialist and Narcan ingredient maker Antheia reels in $56M in series C funding

Biosynthesis specialist and Narcan ingredient maker Ant...

Jun 4, 2025  0